Shopping Cart
- Remove All
- Your shopping cart is currently empty
Daun02 is the topoisomerase inhibitor Daunorubicin prodrug.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $747 | Backorder |
Description | Daun02 is the topoisomerase inhibitor Daunorubicin prodrug. |
In vitro | Daun02 is converted by β-galactosidase to Daunorubicin, which has been shown to reduce Ca2+-dependent action potentials in neuroblastoma cells [1]. Daun02 is a good substrate for β-galactosidase (β-gal) and it also is a topoisomerase inhibitor [2]. The concentration of Daun02 producing 50% (EC50) decrease in cell viability is 0.5 μM, 1.5 μM, and 3.5 μM for T47-D, Panc02, and MCF-7, respectively [3]. |
In vivo | Daun02 is an efficient substrate for β-gal (Km: 0.37 mM; Vmax: 8.6 μmol/min/mg). It demonstrates 79% plasma protein binding, compared to 94% for Daunomycin at 10 μM [3]. |
Molecular Weight | 884.79 |
Formula | C41H44N2O20 |
Cas No. | 290304-24-4 |
Relative Density. | 1.67 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 100 mg/mL (113.02 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.